BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36861213)

  • 1. Of dolphins, humans, other long-lived animals and Alzheimer's disease (Commentary on Vacher et al.).
    Pereyra G; Bovolenta P
    Eur J Neurosci; 2023 Apr; 57(7):1180-1183. PubMed ID: 36861213
    [No Abstract]   [Full Text] [Related]  

  • 2. Do dolphins get Alzheimer's disease?
    Di Guardo G
    Vet Rec; 2019 Dec; 185(24):762. PubMed ID: 31857406
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease, cellular prion protein, and dolphins.
    Di Guardo G
    Alzheimers Dement; 2018 Feb; 14(2):259-260. PubMed ID: 29348035
    [No Abstract]   [Full Text] [Related]  

  • 4. Can dolphins develop Alzheimer's disease?
    Mills G
    Vet Rec; 2023 Jan; 192(1):8-9. PubMed ID: 36607662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al.
    Diomedi M; Stefani A
    Alzheimers Dement; 2015 Sep; 11(9):1123-4. PubMed ID: 25487913
    [No Abstract]   [Full Text] [Related]  

  • 6. Disrupted self in Alzheimer's disease: Beyond midline structures: Commentary on Wong et al.
    Genon S; Salmon E
    Cortex; 2018 Jul; 104():128-129. PubMed ID: 28502534
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyanobacterial neurotoxin BMAA and brain pathology in stranded dolphins.
    Davis DA; Mondo K; Stern E; Annor AK; Murch SJ; Coyne TM; Brand LE; Niemeyer ME; Sharp S; Bradley WG; Cox PA; Mash DC
    PLoS One; 2019; 14(3):e0213346. PubMed ID: 30893348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A commentary on Liang et al.'s paper with regard to emerging views of memory assessment in Alzheimer's disease.
    Parra MA
    Cortex; 2017 Mar; 88():198-200. PubMed ID: 27405258
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulus-induced gamma rhythms are weaker in human elderly with mild cognitive impairment and Alzheimer's disease.
    Murty DV; Manikandan K; Kumar WS; Ramesh RG; Purokayastha S; Nagendra B; Ml A; Balakrishnan A; Javali M; Rao NP; Ray S
    Elife; 2021 Jun; 10():. PubMed ID: 34099103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMAA, Methylmercury, and Mechanisms of Neurodegeneration in Dolphins: A Natural Model of Toxin Exposure.
    Davis DA; Garamszegi SP; Banack SA; Dooley PD; Coyne TM; McLean DW; Rotstein DS; Mash DC; Cox PA
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 80,000-Piece Puzzle of Alzheimer's Disease.
    Iram T; Keller A; Wyss-Coray T
    Immunity; 2019 Jun; 50(6):1349-1351. PubMed ID: 31216459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.).
    Fahrenholz F
    Eur J Neurosci; 2010 Oct; 32(8):1245. PubMed ID: 20973156
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dolphin pointing is linked to the attentional behavior of a receiver.
    Xitco MJ; Gory JD; Kuczaj SA
    Anim Cogn; 2004 Oct; 7(4):231-8. PubMed ID: 15088149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on 'Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease' by Prasanna Satpute-Krishnan et al. Aging Cell Vol. 2, Issue 6, 305-318 (2003).
    Itzhaki RF; Dobson CB; Wozniak MA
    Aging Cell; 2004 Apr; 3(2):79-80. PubMed ID: 15038823
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis and Therapeutic Strategies in Alzheimer's Disease: From Brain to Periphery.
    Yu JT; Zhang C
    Neurotox Res; 2016 Feb; 29(2):197-200. PubMed ID: 26597964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.